AstraZeneca Cancels £450 Million Vaccine Facility Expansion: A Setback for UK Growth

AstraZeneca has scrapped its plans for a £450 million expansion of its flu vaccine facility in Speke, citing inadequate government support as a key factor. This decision comes just days after Chancellor Rachel Reeves emphasized the importance of growth in the life sciences sector. The pharmaceutical giant's withdrawal highlights tensions with the new Labour administration, which failed to match the previous government's funding offer. Despite this setback, AstraZeneca will continue operations at the Speke site, ensuring flu vaccine production remains unaffected. 

 

Source: BBC, News.sky, Cityam